Phillip G. Febbo
CIK 1649245 · Chief Scientific & Med Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.85M
Companies
4
Total Filings
51
Lifetime Open-Market Net
-$3.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCYT | Chief Scientific & Med Officer | 149,797 | $47.22 | $7.07M | -$1.23M | 15 | 2026-06-04 |
| ILMN | SVP Chief Medical Officer | 14,786 | $187.96 | $2.78M | -$1.72M | 17 | 2023-03-03 |
| VARIAN MEDICAL SYSTEMS INC (VAR) Delisted | Director | 9 | $177.07 | $1.6K | $0 | 4 | 2021-04-16 |
| GENOMIC HEALTH INC (GHDX) Delisted | Chief Medical Officer | 21,687 | — | — | -$713.2K | 10 | 2018-02-22 |
Recent Filings · Page 5 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-07 | ILMN | Tax (F) | −83 | -$25.0K | EDGAR |
| 2018-02-22 | GENOMIC HEALTH INC (GHDX) Delisted | Sell (S) | −4,942 | -$162.3K | EDGAR |
| 2018-02-20 | GENOMIC HEALTH INC (GHDX) Delisted | Tax (F) | −2,801 | -$91.5K | EDGAR |
| 2018-02-02 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +11,330 | $0 | EDGAR |
| 2017-12-20 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | −334 | -$62.3K | EDGAR |
| 2017-07-21 | GENOMIC HEALTH INC (GHDX) Delisted | Sell (S) | −3,174 | -$106.5K | EDGAR |
| 2017-02-17 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | −4,405 | -$134.5K | EDGAR |
| 2017-02-02 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +11,440 | $0 | EDGAR |
| 2016-12-20 | GENOMIC HEALTH INC (GHDX) Delisted | Tax (F) | −2,131 | -$55.2K | EDGAR |
| 2016-05-12 | GENOMIC HEALTH INC (GHDX) Delisted | Sell (S) | −6,324 | -$172.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.